- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 20, 2026 | 225.57M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 237.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 271.9M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2.2M |
| Capex | Q1 2026 · Mar 31, 2025 | $15.5M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$226.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$186.9M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $7.26B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.51B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $754.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $493.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.59B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$2.55B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $498.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.5B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $848.5M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.1B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.32B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.8B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.44B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.37B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $23.15 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $2.88 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $24.45 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $3.55 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $109.2M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $108.9M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $58.2M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $66.2M |
| Net Income | Q1 2026 · Mar 31, 2026 | $5.51B |
| Net Income | Q1 2026 · Mar 31, 2025 | $784M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $23.7M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$16.3M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $233.7M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $197.6M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $238.1M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $190.5M |
| Revenue | Q1 2026 · Mar 31, 2026 | $471.8M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $388.1M |